References
- Johnson AC, Nagle KJ, Tremble SM, Cipolla MJ. The contribution of normal pregnancy to eclampsia. PLoS One 2015;10:e0133953.
- Chen Y, Xun D, Wang YC, et al. Incidence and risk factors of retinopathy of prematurity in two neonatal intensive care units in North and South China. Chin Med J (Engl) 2015;128:914–8.
- Dekker GA. Management of preeclampsia. Pregnancy Hypertens 2014;4:246–7.
- Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: An update. Acta Anaesthesiol Belg 2014;65:137–49.
- Das UN. Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids. Nutrition 2015;31:1083–95.
- Amaral LM, Cunningham MW Jr, Cornelius DC, LaMarca B. Preeclampsia: Long-term consequences for vascular heath. Vasc Health Risk Manag 2015;11:403–15.
- Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res 2008;75:1–8.
- Saito S, Nakashima A. A review of the mechanism for poor placentation in early-onset preeclampsia: The role of autophagy in trophoblast invasion and vascular remodeling. J Reprod Imunol 2014;101–102:80–8.
- Allen RE, Rogozinska E, Cleverly K, et al. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: A meta-analysis. Eur J Obstet Gynecol Reprod Biol 2014;182:194–201.
- Spinillo A, Gardella B, Bariselli S, et al. Placental histopathological correlates of umbilical artery Doppler velocimetry in pregnancies complicated by fetal growth restriction. Prenat Diagn 2012;32(13):1263–72.
- Akehurst C, Small HY, Sharafetdinova L, et al. Differential expression of microRNA-206 and its target genes in preeclampsia. J Hypertens 2015;33:2068–74.
- Murphy MS, Casselman RC, Tayade C, Smith GN. Differential expression of plasma microRNA in preeclamptic patients at delivery and 1 year postpartum. Am J Obstet Gynecol 2015;213:367. e1–9.
- Maged AM, EINassery N, Fouad M, et al. Third-trimester uterine artery Doppler measurement and maternal postpartum outcome among patients with severe pre-eclampsia. Int J Gynaecol Obstet 2015;131:49–53.
- Nagar T, Sharma D, Choudhary M, et al. The role of uterine and umbilical arterial Doppler in high-risk pregnancy: A prospective observational study from India. Clin Med Insights Reprod Health 2015;9:1–5.
- Loui A, Eilers E, Strauss E, et al. Vascular Endothelial growth factor (VEGF) and soluble VEGF receptor 1 (sFlt-1) levels in early and mature human milk from mothers of preterm versus term infants. J Hum Lact 2012;28:522–8.
- Makey KL, Patterson SG, Robinson J, et al. Increased plasma levels of soluble vascular endothelial growth factor receptor (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women. Eur J Cancer Prev 2013;22:83–9.
- Di Marco GS, Reuter S, Hillebrand U, et al. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. J Am Soc Nephrol 2009;20:2235–45.
- Tannetta DS, Dragovic RA, Gardiner C, et al. Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS One 2013;8:e56754.
- Olmos CS, Macedo MA, Pereira RM, et al. SFlt-1: A possibility of precocious diagnosis of preeclampsia. Pregnancy Hypertens 2012;2:335–6.
- Redman CW. Stress response and pre-eclampsia. Pregnancy Hypertens 2013;3:57.
- Nevo O, Lee DK, Caniggia I. Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta. PLoS One 2013;8:e81176.
- De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med 2012;44:1–9.
- Kim KJ, Cho CS, Kim WU. Role of placenta growth factor in cancer and inflammation. Exp Mol Med 2012;44:10–9.
- Le Jie. Gynecotokology. The 7th edition. Beijing Publishing House of the People’s Health 2008:38–40
- Bates DO. An unexpected tail of VEGF and PLGF in pre-eclampsia. Biochem Soc Trans 2011;39:1576–82.
- Kar M. Role of biomarkers in early detection of preeclampsia. J Clin Diagn Res 2014;8(4):BE01–4.
- Anderson UD, Olsson MG, Kristensen KH, et al. Review: Biochemical markers to predict preeclampsia. Placenta 2012;33 Suppl:S42–7.
- Levine RJ, Thadhani R, Qian C, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005;293(1):77–85.